PatientsLikeMe ™

all
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Filter page content by community
All Communities

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Restasis

What is Cyclosporin? Cyclosporin is an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It has been studied in transplants of skin, heart, kidney, lung, pancreas, bone marrow and small intestine.


Reasons Taken

13 patients in the community are taking or have taken Cyclosporin.

Dosages

Based on the patients currently taking Cyclosporin.

  0 day 0 mL none 0.05 g day 0.05 day 0.1 g day 1 day 2 day 300 mg day
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Cyclosporin or how long patients were taking Cyclosporin before stopping.

Currently taking Cyclosporin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
0
0
5
3

Stopped taking Cyclosporin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
0
2
Why Patients Stopped Taking Cyclosporin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 1 33% Did not seem to work: 33%
Side effects too severe 1 33% Side effects too severe: 33%
Course of treatment ended 1 33% Course of treatment ended: 33%

Patient Reported Evaluations

Results from 3 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 100% 1

Inflammation of interior of eye (Pars planitis)

Side-effects (as an overall problem)

Severe 0% 0
Moderate 0% 0
Mild 0% 0
None 100% 3

Top reported side-effects include:

Summary results are based on 3 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (1 of 3)

  • Yuman
    Mouth/throat: moderate
    Arms: moderate
    Chest: mild
    Legs: moderate
  • Yuman
  • by Yuman
    Oct 29, 2008
  • EfficacyModerate
  • Side-effectsNone
  • Other

See all evaluation results for Cyclosporin



Back to top